Skip to Content
AP National Business

States reach deal over marketing, safety of generic opioids

KIFI
By
Published 11:26 AM

By MARK SCOLFORO
Associated Press

HARRISBURG, Pa. (AP) — A former opioid manufacturer is agreeing in principle to pay up to $2.4 billion in a deal with a dozen states over its marketing and product safety practices. State attorneys general announced the deal Friday regarding Allergan’s practices. Allergan is now part of AbbVie but sold its generics division Actavis,  including its opioid products, to Teva Pharmaceuticals six years ago. The settlement calls for payments to be made to state and local governments. The agreement means pharma companies have consented to pay more than $40 billion to settle opioid crisis claims regarding manufacturers and distributors, The Associated Press has found.

Article Topic Follows: AP National Business

Jump to comments ↓

Author Profile Photo

Associated Press

BE PART OF THE CONVERSATION

KIFI Local News 8 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content